References
Oliver JW, Deol I, Morgan DL, Tonk VS (1998) Chronic eosinophilic leukemia and hypereosinophilic syndromes. Proposal for classification, literature review, and report of a case with a unique chromosomal abnormality. Cancer Genet Cytogenet 107:111–117
Sanderson CJ (1992) Interleukin-5, eosinophils, and disease. Blood 79:3101–3109
Suzuki S, Chiba K, Toyoshima N, Kurosawa M, Hashino S, Musashi M, Asaka M (2001) Chronic eosinophilic leukemia with t(6;11)(q27;q23) translocation. Ann Hematol 80:553–556
Cools J, Deangelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J, Kutok J, Clark J, Galinsky I, Griffin JD, Cross NC, Tefferi A, Malone J, Alam R, Schrier SL, Schmid J, Rose M, Vandenberghe P, Verhoef G, Boogaerts M, Wlodarska I, Kantarjian H, Marynen P, Coutre SE, Stone R, Gilliland DG (2003) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 348:1201–1214
Cools J, Stover EH, Wlodarska I, Marynen P, Gilliland DG (2004) The FIP1L1–PDGFR alpha kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia. Curr Opin Hematol 11:51–57
Acknowledgments
This study was supported by research funds from Chosun University, 2003
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, C.Y., Chung, C.H. & Park, Y.J. Chronic eosinophilic leukemia with 46,XY,1,der(1;7)(q10;p10) translocation. Ann Hematol 83, 547–548 (2004). https://doi.org/10.1007/s00277-004-0875-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-004-0875-6